SECuRE: A dose escalation/expansion study to assess the anti-tumor efficacy of 67Cu-SAR-bisPSMA in patients with metastatic castrate-resistant prostate cancer.

Overview of attention for article published in Journal of Clinical Oncology, January 2024

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (62nd percentile)

Mentioned by

patent: 1 patent

Readers on

mendeley: 3 Mendeley

So far, Altmetric has seen 1 patent that references this research output.

METHODS FOR THE DIAGNOSIS AND/OR TREATMENT OF PROSTATE CANCER

Application WO-2024234061-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity.